PT  - JOURNAL ARTICLE
AU  - Nierengarten, Mary Beth
ED  - Bueno, Héctor
TI  - No Increased Coronary or Mortality Risk Associated with Changes in DAPT
DP  - 2014  01
TA  - MD Conference Express
PG  - 9--10
VI  - 14
IP  - 42
4099  - http://mdc.sagepub.com/content/14/42/9.short
4100  - http://mdc.sagepub.com/content/14/42/9.full
AB  - For patients discharged after acute coronary syndrome (ACS), changing from dual-antiplatelet therapy (DAPT) to less potent antiplatelet therapy is not associated with increased coronary or mortality risk despite a short-term excess of cardiovascular (CV) events. This article presents the results of the Long-term Follow-up of Anti-thrombotic Management Patterns in Acute Coronary Syndrome Patients [EPICOR; NCT01171404], a real-world-practice cohort study conducted to describe current international patterns of DAPT use following ACS and the clinical outcomes associated with changes in DAPT.